Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-16

Clinical Trial Update: Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating venetoclax in combination with intensive induction and consolidation chemotherapy in treatment-naïve acute myeloid leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venetoclax (venetoclax)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING